CPGP · Question #476
Which document details post-approval changes in pharmaceutical manufacturing? Response:
The correct answer is A. SUPAC guidelines. SUPAC (Scale-Up and Post-Approval Changes) guidelines are FDA documents specifically designed to address changes made after a drug product receives approval - covering manufacturing site changes, batch size, equipment, and formulation modifications. A Product Monograph…
Question
Which document details post-approval changes in pharmaceutical manufacturing? Response:
Options
- ASUPAC guidelines
- BProduct Monograph
- CClinical Trial Report
- DMarketing Authorization
How the community answered
(36 responses)- A83% (30)
- B3% (1)
- C3% (1)
- D11% (4)
Explanation
SUPAC (Scale-Up and Post-Approval Changes) guidelines are FDA documents specifically designed to address changes made after a drug product receives approval - covering manufacturing site changes, batch size, equipment, and formulation modifications. A Product Monograph describes a drug's properties, indications, and safety profile for prescribers, not manufacturing change procedures. A Clinical Trial Report documents the results of clinical studies conducted before approval. A Marketing Authorization is the regulatory approval itself, granting permission to market the drug - it is the outcome of the approval process, not a guide for managing changes afterward.
Memory tip: Think of SUPAC as the "what happens after the yes" document - Scale-Up and Post-Approval Changes covers everything a manufacturer needs to do once approval is granted and production scales or shifts.
Community Discussion
No community discussion yet for this question.